04:51 PM EDT, 09/06/2024 (MT Newswires) -- Vaxcyte ( PCVX ) said Friday it closed an underwritten public offering of about 12.1 million in common shares at $103 apiece and pre-funded warrants to buy about 2.4 million shares at $102.999 per warrant, for gross proceeds of $1.5 billion.

This includes the underwriters fully exercising their option to buy up to 1.9 million additional shares of common stock at the public offering price, minus underwriting fees.

Price: 111.65, Change: +0.07, Percent Change: +0.06